Therapeutic potentials of fasudil in liver fibrosis  

作　　者：Yue Xi Peng-Fei Xu 

机构地区：[1]Center for Pharmacogenetics and Department of Pharmaceutical Sciences,University of Pittsburgh,Pittsburgh,PA 15261,United States

出　　处：《World Journal of Gastroenterology》2021年第45期7859-7861,共3页世界胃肠病学杂志（英文版）

摘　　要：Fasudil has the potential to prevent liver fibrosis by activating natural killer cells and inhibiting the proliferation of hepatic stellate cells.Fasudil may be a promising clinical therapeutic drug for the prevention and treatment of liver fibrosis.

关 键 词：FASUDIL Liver fibrosis Natural killer cell Hepatic stellate cell Clinical therapeutic drug 

分 类 号：R575.2[医药卫生—消化系统]